Market Closed -
Toronto S.E.
08:30:00 16/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.105
CAD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: July |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
0.45
|
0.35
|
0.3627
|
0.4426
|
Enterprise Value (EV)
1 |
0.2282
|
0.1401
|
0.2902
|
0.3631
|
P/E ratio
|
-2.67
x
|
-7.31
x
|
-2.45
x
|
-2.33
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
10,20,34,884
x
|
-80,63,820
x
|
-36,86,971
x
|
-33,87,941
x
|
FCF Yield
|
0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
2.04
x
|
1.68
x
|
5.03
x
|
5.38
x
|
Nbr of stocks (in thousands)
|
2,500
|
2,500
|
2,590
|
4,215
|
Reference price
2 |
0.1800
|
0.1400
|
0.1400
|
0.1050
|
Announcement Date
|
15/10/20
|
08/11/21
|
16/11/22
|
27/11/23
|
Fiscal Period: July |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.2526
|
-0.0744
|
-0.0288
|
-0.1234
|
-0.1664
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.265
|
-0.0878
|
-0.0426
|
-0.1449
|
-0.1897
|
Net income
1 |
-0.265
|
-0.0878
|
-0.0426
|
-0.1449
|
-0.1897
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-0.0674
|
-0.0192
|
-0.0571
|
-0.0450
|
Free Cash Flow
|
-
|
0.002236
|
-0.0174
|
-0.0787
|
-0.1072
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/10/19
|
15/10/20
|
08/11/21
|
16/11/22
|
27/11/23
|
Fiscal Period: July |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
0.12
|
0.22
|
0.21
|
0.07
|
0.08
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0
|
-0.02
|
-0.08
|
-0.11
|
ROE (net income / shareholders' equity)
|
-
|
-48.8%
|
-19.9%
|
-104%
|
-246%
|
ROA (Net income/ Total Assets)
|
-
|
-25.6%
|
-8.29%
|
-53.5%
|
-127%
|
Assets
1 |
-
|
0.3436
|
0.5139
|
0.2711
|
0.1496
|
Book Value Per Share
2 |
0.2800
|
0.0900
|
0.0800
|
0.0300
|
0.0200
|
Cash Flow per Share
2 |
0.2500
|
0.0900
|
0.0800
|
0.0300
|
0.0200
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/10/19
|
15/10/20
|
08/11/21
|
16/11/22
|
27/11/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 325K | | +16.59% | 44.44B | | +41.02% | 40.03B | | -10.62% | 37.68B | | +29.92% | 31.46B | | -9.23% | 27.29B | | +12.34% | 26.29B | | +41.53% | 13.8B | | +31.49% | 12.46B | | -7.40% | 11.26B |
Other Biotechnology & Medical Research
|